GlobeNewswire

YouVersion Bible App celebrates 10th anniversary

Dela

Most downloaded Bible app helps change Bible engagement worldwide

 

OKLAHOMA CITY, July 09, 2018 (GLOBE NEWSWIRE) -- This July, YouVersion celebrates the 10-year anniversary of the Bible App, which was one of the first 200 free apps available when Apple launched the App Store on July 10, 2008. In the decade since, the Bible App has been downloaded on more than 330 million devices and in every country of the world.

"We never could have predicted the results we've seen as millions of people around the world have read, listened to, shared, and interacted with the Bible and each other in new ways," said Bobby Gruenewald, Life.Church Pastor, Innovation Leader and YouVersion Founder.

After seeing 83,000 installs of the Bible App in the first three days, it went on to reach 10 million installs in 2010, 50 million installs in 2012, and 100 million installs in 2013. In the last decade, people have used the Bible App to: 

  • Read 70 billion chapters of the Bible 
  • Listen to 12 billion audio chapters of the Bible
  • Make 4 billion Highlights, Bookmarks, and Notes 
  • Complete 2.4 billion Bible Plan days 

"Early on, we discovered that proximity helped us engage with the Bible," said Gruenewald. "As soon as I had access to the Bible on the phone that's always in my pocket, my connection to it naturally became more frequent."

As the Bible App grew, users cited the ability to quickly switch between different versions of the Bible as a favorite feature. The app, which initially launched with 15 versions and two languages, has since partnered with publishers and Bible societies to offer more than 1,700 different versions of the Bible, including Bible text in more than 1,200 languages. 

With smartphones propelling social media platforms to new heights, the YouVersion community quickly adopted social sharing features as they were added to the app. Over the last decade, Bible App users have shared more than 950 million Bible verses, earning the Bible a prominent place in people's lives and social media feeds.

Recognizing the opportunity to bring more relational interaction around the Bible, YouVersion introduced community features such as a home feed of friends' activity and the ability to study the Bible together. Through Plans with Friends, people can connect and discuss the Bible when they aren't in the same room, or even the same country. This feature helped change the life of a New Jersey native, Adora, who used the Bible App to rebuild a relationship with her mother.

"When I started using the Bible App, I hadn't seen or spoken to my mother in 10 years," said Adora. "After several months of reading Bible Plans about forgiveness and healing, I decided to offer my mom a relationship with me-but only in the Bible App."

Adora added her mother as a Friend in the Bible App and sent an invitation to do a Bible Plan together using the Plans with Friends feature. As they talked about what they were reading, they opened up about mutual feelings of hurt and anger. They slowly went from only talking in the Bible App, to texting, and then meeting in person to pray.

"I never, ever thought that I would have a relationship with my mom again," said Adora. "But by reading the Bible and doing these daily plans, God has worked a miracle on my heart and in my life."

Beyond shaping the way we interact with Scripture and each other, the Bible App has introduced a way for the Bible to reach us in our everyday lives. Features like Verse of the Day notifications, reading reminders, and daily Streaks have helped people develop new Bible-reading habits, sometimes after years of trying to do so on their own.

"When people install the Bible App, it's usually because they want to read it more. So we've spent a lot of time thinking about how to help them do what they want to do," said Gruenewald. 

Each new feature is targeted to increase daily engagement from the YouVersion community. Since adding features like daily Streaks and Perfect Weeks, the number of daily active users has increased by more than 30 percent compared to last year.

"These last 10 years have been more than we could ask, think, or imagine, and we believe this is only the beginning," said Gruenewald. "As we look ahead, we're excited about the new ways God is using technology to help people make even more connections between the Bible and their daily lives."

YouVersion will soon launch Bible Lens, a new app that analyzes the objects in a photo and detects biblical themes to suggest the Bible verse that best fits the photo. Then, it automatically designs a high-quality Verse Image that can be shared with friends. Additionally, the app will have the ability to create Verse Images from photos saved in a person's camera roll to help them rediscover every moment of their life through the lens of the Bible.

Visit blog.youversion.com to stay updated on YouVersion and its products.

About YouVersion             
YouVersion was created by Life.Church to help people engage with the Bible. The team designs and builds experiences that make it easy for people to integrate the Bible into their everyday lives. Since 2008, the Bible App has offered a free Bible experience on smartphones, tablets, and computers that allows people to read the Bible at any time and in any place. In 2013, YouVersion launched the Bible App for Kids, in partnership with OneHope, to engage children with beautifully illustrated, interactive Bible adventures. For more information about YouVersion, visit www.youversion.com.

Rachel Feuerborn 
405-216-7072 
press@youversion.com

Photos accompanying this announcement are available at

http://www.globenewswire.com/NewsRoom/AttachmentNg/f30266ec-0b9d-4f60-ab42-9873bd1a7cdc

http://www.globenewswire.com/NewsRoom/AttachmentNg/463935be-157a-4c29-ba41-d011cdd62e3d




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: YouVersion via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Stillfront Group rekryterar ansvarig för M&A19.12.2018 12:07Pressmeddelande

PRESSMEDDELANDE 19 december, 2018 Stillfront Group rekryterar ansvarig för M&A Stillfront Group, en marknadsledare inom 'free to play' online strategispel, annonserar idag att Marina Andersson har utsetts till ansvarig för M&A och kommer att ingå i koncernledningen. Marina har närmare tjugo års erfarenhet från investment banking och M&A. Hon har omfattande erfarenhet inom strategisk och finansiell rådgivning, affärsgenerering, projektledning inom förvärv och försäljningar av företag, finansiell analys, due diligence, samt företagsvärdering. Tidigare positioner inkluderar: Director, Deloitte's Corporate Finance Advisory team, Director, ICECAPITAL Securities, Associate Partner och Investment Manager, Deseven, samt M&A Analytiker på Carnegie. Marina har två magister-examen från Stockholms universitet och Russian Herzen State Pedagogical University. "Förvärv är en viktig del av Stillfronts affärsstrategi och vi är mycket glada att rekrytera Marina Andersson. Marinas breda erfarenhet och pr

Stillfront Group announces Head of M&A19.12.2018 12:07Pressmeddelande

PRESS RELEASE December 19, 2018 Stillfront Group announces Head of M&A Stillfront Group, a market leader in 'free to play' online strategy games, today announces that Marina Andersson has been appointed as Head of M&A and will be part of the Group's management team. Marina has close to 20 years track record of investment banking and M&A. She has extensive competence within strategic and financial advisory, deal generation, buy and sell side M&A project management, financial analysis, due diligence and company valuation. Former positions include: Director at Deloitte's Corporate Finance Advisory team, Director at ICECAPITAL Securities, Associate Partner and Investment Manager at Deseven, M&A Analyst at Carnegie. She holds two Master degrees from Stockholm University and Russian Herzen State Pedagogical University. "Acquisitions are a crucial part of Stillfront's business strategy and we are very pleased with the appointment of Marina Andersson. Marina's breadth of experience and profess

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum